A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women

Author： Salobir B.G.u.   Keber I.   Vrabic L.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.78, Iss.6, 2002-12, pp. : 1178-1183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women

By Sator P.-G.   Sator M. O.   Schmidt J. B.   Nahavandi H.   Radakovic S.   Huber J. C.   Honigsmann H.  

Climacteric, Vol. 10, Iss. 4, 2007-08 ,pp. : 320-334

Informa Healthcare

Access to resources Recommend Favorite

Effects of raloxifene and hormone replacement therapy on serum Th2 and Th3 type cytokine concentrations in healthy postmenopausal women: a randomised controlled trial

By Kumru Selahattin  

Archives of Gynecology and Obstetrics, Vol. 277, Iss. 6, 2008-06 ,pp. : 489-493

Springer Publishing Company

Access to resources Recommend Favorite

A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women

By Endrikat Jan   Lange Evelyn   Kunz Michael   Schmidt Werner   Graeser Thomas  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 229-239

Informa Healthcare

Access to resources Recommend Favorite

Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function

By Teede H. J.   Liang Y.-L.   Kotsopoulos D.   Zoungas S.   Craven R.   McGrath B. P.  

Climacteric, Vol. 5, Iss. 2, 2002-06 ,pp. : 160-169

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist plus ''add-back'' hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial

By Franke H.R.   van de Weijer P.H.M.   Pennings T.M.M.   van der Mooren M.J.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 534-539

Elsevier

Access to resources Recommend Favorite